BHS Clinical Trials

CMV specific T cell therapy for the treatment of relapsing or therapy refractory CMV infection after allogenic stem cell transplantation with a CMV-positive donor
Allogeneic hematopoietic cell transplantation with HLA-matched donors : a phase II randomized study comparing 2 nonmyeloablative conditionings
Infusion of mesenchymal stem cells as treatment for steroid resistant grade II to IV acute GVHD or poor graft function: a multicenter phase II study
Co-transplantation of mesenchymal stem cells and HLA-mismatched allogeneic hematopoietic cells after nonmyeloablative conditioning: a phase II randomized double-blind study
A pilot study to assess the feasibility of unrelated umbilical cord blood transplantation with coinfusion of third-party mesenchymal stem cells after myeloablative or nonmyeloablative conditioning in adult patients with hematological malignancies
Randomized double-blind study of mesenchymal stem cells (MSC) in patients undergoing matched unrelated allogeneic bone marrow or peripheral blood stem cell transplantation -A European multicentre study
Prevention and treatment of severe GVHD after allogeneic hematopoietic stem cell transplantation, applied as consolidation immunotherapy in patients with hematological malignancies. A prospective randomized phase III trial
TC07 Allogeneic hematopoietic cell transplantation from HLA-matched donors after reduced-intensity conditioning: a phase II randomized study comparing 2 GVHD prophylaxis regimen
Busulfan dosage in allogeneic stem cell transplant recipients receiving PO Busulfan containing conditioning regimens
Wilms’ tumor (WT1) antigen-targeted dendritic cell vaccination to prevent relapse in patients older than 65 years with acute myeloid leukemia: a multicenter randomized phase II trial
Sequential administration of 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation
A Phase II study to assess the safety and the efficacy of extracorporeal photopheresis (ECP) using the Theraflex ECP™ for patients with refractory chronic GVHD
Allogeneic hematopoietic cell transplantation from HLA-matched donor after Flu-Mel versus Flu-Mel-ATG reduced-intensity conditioning - a phase III randomized study from the Belgian Hematology Society (BHS)